Small vessel size (<3 mm) has been identified as an independent predictive factor of restenosis after percutaneous coronary intervention when using bare metal stents (BMS). It remains controversial whether BMS placement in small vessels has an advantage over balloon angioplasty in terms of angiographic and clinical outcomes. The advent of drug eluting stents (DES), either paclitaxel-eluting stents (PES) or sirolimus-eluting stents (SES), has strongly impacted interventional cardiology by significantly reducing restenosis and the need for repeat revascularization. Therefore, it was also expected that DES could substantially reduce restenosis in smaller vessels. However, even in the DES era, small vessel size remains an independent predictor of angiographic and clinical restenosis. To date, only a few studies systematically investigate the clinical effect of DES placement in small vessels. In addition, some potential issues with the use of DES have been raised, such as late stent thrombosis and late restenosis. In order to (i) establish the superiority of DES over BMS; (ii) verify the efficacy and safety of DES; and (iii) critically assess the superiority of one DES over the other in patients with small coronary arteries, further multicenter, randomized clinical trials with larger sample size are warranted.
A comprehensive numerical investigation into the cross-sectional behaviour and ultimate capacity of non-slender welded I-sections, made of both normal and high strength steels (NSS and HSS), under combined compression and uniaxial bending is presented. Finite element (FE) models were initially established and validated against test results collected from the literature. Subsequently, parametric studies were conducted using the validated FE models to generate extensive numerical data considering different steel grades, cross-section geometries and loading combinations. The obtained numerical data, together with the test results collected from the literature, were utilised to assess the accuracy of the traditional European (EC3) and North American (AISC) design provisions, as well as the Continuous Strength Method (CSM), for NSS and HSS welded I-sections under combined loading. The assessment indicated that the CSM was able to provide more accurate and consistent resistance predictions than the current EC3 and AISC design provisions owing to its ability to capture the spread of plasticity and strain hardening in a systematic, mechanics-based manner. Finally, the reliability levels of the different design methods were statistically evaluated in accordance with EN 1990:2002.
No abstract is provided for this article.
Intravenous carbon dioxide (CO2) was employed to cause echocardiographic contrast in 40 patients. One to 3 cc of medically pure CO2 were agitated with 5 to 8 cc of 5% dextrose in water and rapidly injected into an upper extremity vein. Contrast was obtained in all patients. In 33 patients contrast density from 5% dextrose was compared with that from 5% dextrose-CO2 injections. Six of these patients had no contrast on the initial 5% dextrose injection and definite contrast with the subsequent injection containing CO2. Of the 33, 12 patients had initial contrast with 5% dextrose injections and greater contrast density when CO2 was added; 15 showed no definite difference; and none had less contrast with intravenous CO2-5% dextrose than with 5% dextrose alone. Intravenous CO2-5% dextrose is a useful method of increasing contrast in those patients who fail to demonstrate echocardiographic contrast when routine techniques are employed. It is also safe, provided precautions emphasized in this paper are observed.